Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2010-04-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Appendix 4C - quarterly 6 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C – Quarterly cash report' and is addressed to the ASX Companies Announcements Office. It contains detailed quarterly cash flow statements, including operating, investing, and financing activities, for the quarter ended 31 March 2010. The document includes reconciliations of cash, payments to directors, and compliance statements referencing accounting standards. The length is 8422 characters, which is substantial and contains actual financial data, not just an announcement or certification. The Appendix 4C is a recognized quarterly cash flow report required by the ASX for entities admitted on the basis of commitments. This fits the definition of an Interim / Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year, including substantive financial statements and analysis. Therefore, the correct classification is IR. Q3 2010
2010-04-29 English
Half Yearly Report and Accounts 18 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D – Half Year Report' and covers the half-year ended 31 December 2009. It includes detailed financial statements such as Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flow, along with Directors' Report and Auditor's Independence Declaration. The content is comprehensive and contains actual financial data and analysis for a period shorter than a full fiscal year. The document is not a brief announcement or a certification but a full interim financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2010
2010-02-25 English
Appendix 4C - quarterly 5 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C Quarterly report for entities admitted on the basis of commitments' and contains detailed financial data including consolidated statement of cash flows, cash flow related to operating, investing, and financing activities, reconciliation of cash, and compliance statements. The report covers a quarter ended 31 December 2009 and includes substantive financial data and analysis. The length of the document (7036 characters) and the detailed financial content indicate it is a financial report rather than a brief announcement or certification. The document matches the characteristics of an Interim / Quarterly Report (IR) as it provides comprehensive financial information for a period shorter than a full fiscal year (quarterly). H1 2009
2010-01-27 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a communication from Probiomics Limited to the Australian Stock Exchange Companies Announcements Office dated 26 November 2009. It reports the results of resolutions passed at the Annual General Meeting held on 25 November 2009. The content includes voting results for specific resolutions such as ratification of share issues, election of a director, and remuneration policy approval. There are no financial statements or detailed financial analysis present, only the official voting outcomes. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is short and focused solely on voting results, not the full AGM materials or annual report. Therefore, the correct classification is DVA with high confidence.
2009-11-25 English
Chairman`s Address to Shareholders 3 pages ?Kb
AGM Information Classification · 95% confidence The document is titled 'Chairman’s AGM Speech' and is dated 25 November 2009. It is a speech delivered at the Annual General Meeting (AGM) of Probiomics Limited. The content includes a summary of the company's financial and operational progress, key business milestones, and future opportunities, which are typical elements of an AGM presentation. There is no detailed financial statement or comprehensive annual report data, nor is it a brief announcement or certification. The document is a presentation or speech given at the AGM, which fits the category of AGM Information (AGM-R). The document length (5944 characters) supports it being a full speech rather than a short announcement. Therefore, the appropriate classification is AGM Information (AGM-R).
2009-11-24 English
PROBIOMICS SIGNS AN EXCLUSIVE AGREEMENT WITH CHR. HANSEN 3 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 24th November 2009 from Probiomics Limited to the Australian Stock Exchange. It announces the signing of an exclusive global distribution agreement with Chr. Hansen A/S. The content focuses on the business deal, the significance of the agreement, and background information about both companies. There are no financial statements, no detailed financial performance data, no regulatory certifications, or voting results. The document is a corporate announcement about a capital or business development event related to financing or partnership. It is not an annual report, earnings release, or management report. The best fitting category is Capital/Financing Update (CAP) as it relates to a major agreement impacting the company's commercial and financial prospects.
2009-11-23 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.